Healthcare

According to a market report by Lucintel, the future of the metagenomic sequencing market looks promising with opportunities in drug discovery, clinical diagnostic, soil microbiome, industrial, ecological and environment, and veterinary markets. The global metagenomic sequencing market is expected to reach an estimated $4.7 billion by 2028 with a CAGR of 17.0% from 2023 to 2028. The major drivers for this market are increasing advancements in DNA sequencing, continuous technological innovations in NGS platform, and growing initiatives and funding from government & private bodies for large-scale sequencing projects.



In this market, reagents & consumables, instruments, services, and analysis & data interpretation solutions are the different segments of metagenomic sequencing by product & service. Lucintel forecasts that reagents & consumables will remain the largest segment over the forecast period due to growing requirement of sequencing reagents by end users and increasing development & commercialization of high-quality reagents & kits.  



Within this market, drug discovery segment is expected to remain largest segment due to increasing research activities for novel drug discovery, growing demand from pharmaceutical companies for innovative drug development, and rising usage of metagenomic in clinical trials.



North America is expected to remain largest region during the forecast period due to increasing initiatives by governments and private bodies for the development and adoption of next generation sequencing-based data analysis in the region.

Thermo Fisher Scientific, Illumina, BGI, Agilent, Eurofins Scientific, QIAGEN, GENEWIZ, Novogene, and PerkinElmer are the major suppliers in the global metagenomic sequencing market.



Lucintel, a leading global strategic consulting and market research firm, has analysed growth opportunities in the global metagenomic sequencing market by product & service, workflow, technology, application, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Metagenomic Sequencing Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global metagenomic sequencing market by product & service, workflow, technology, application, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the metagenomic sequencing market by product & service (reagents & consumables, instruments, services, and analysis & data interpretation solutions), workflow (sample processing & library preparation, sequencing, data processing & analysis), technology (shotgun metagenomic sequencing, 16s rRNa sequencing, metatranscriptomics, whole-genome sequencing & de novo assembly), application (drug discovery, clinical diagnostics, soil microbiome, industrial, ecological and environments, and veterinary) and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity did occur in the last five years and how did they impact the industry?